US Stock MarketDetailed Quotes

YMAB Y-mAbs Therapeutics

Watchlist
  • 17.310
  • +0.060+0.35%
Trading May 3 11:55 ET
759.44MMarket Cap-35326P/E (TTM)

About Y-mAbs Therapeutics Company

Y-mAbs Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of antibody based therapeutic products for the treatment of cancer. Its services include discovery, protein engineering, clinical and regulatory. Y-mAbs Therapeutics was founded by Thomas Gad in April 2015 and is headquartered in New York, NY.

Company Profile

SymbolYMAB
Company NameY-mAbs Therapeutics
Listing DateSep 21, 2018
Issue Price16.00
Founded2015
CEOMr. Michael Rossi
MarketNASDAQ
Employees100
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address230 Park Avenue,Suite 3350
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10169-0005
Phone1-646-885-8505
Websitehttp://www.ymabs.com

Company Executives

  • Name
  • Position
  • Salary
  • Michael Rossi
  • Director, President and Chief Executive Officer
  • 3.11M
  • Sue Smith
  • Senior Vice President and Chief Commercial Officer
  • 887.28K
  • Thomas Gad
  • Vice Chairman of the Board and Chief Business Officer
  • 2.45M
  • Vignesh Rajah
  • Senior Vice President and Chief Medical Officer
  • --
  • Dr. Torben Lund-Hansen, PhD
  • Senior Vice President and Chief Technical Officer
  • --
  • Dr. Steen Lisby
  • Senior Vice President and Chief Scientific Officer
  • --
  • Bo Kruse
  • Executive Vice President, Principal Accounting Officer, Chief Financial Officer, Secretary and Treasurer
  • 1.06M
  • Joris Wiel Jan Wilms
  • Senior Vice President and Chief Operating Officer
  • --
  • Dr. James I. Healy, M.D.,PhD
  • Chairman of the Board
  • 184.31K
  • Dr. Mary A. Tagliaferri, M.D.
  • Director
  • --
  • David N. Gill
  • Independent Director
  • 180.56K
  • Dr. Ashutosh Tyagi, M.D.
  • Independent Director
  • 158.06K
  • Johan Wedell-Wedellsborg
  • Independent Director
  • 158.06K
  • Laura J. Hamill
  • Independent Director
  • 168.06K
  • Dr. Gerard Ber, PhD
  • Independent Director
  • 155.56K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg